Prot #NU 16H07: Phase II Trial of Pembrolizumab in Combination with ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date4/3/174/3/26

Funding

  • Merck Sharp & Dohme Corporation ((OE) Prot #NU 16H07)